Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CombAT: Dutasteride and Tamsulosin in BPH
NCT00090103Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2003
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 36
01
Overview
A Phase 3 trial of dutasteride in benign prostatic hyperplasia (BPH), sponsored by GSK. Started Nov 2003; status: completed.
02
Drugs
dutasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00090103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090103.